Mark Chi Ho Mak
Research Subjects
Research Interests
Mark Chi Ho Mak has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Chi Tung Choy
Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China
1 shared publication - Chun Keung Pang
School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China
1 shared publication - Eddie Chung Ting Chau
School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China
1 shared publication - George Pak-Heng Leung
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 999077, Hong Kong Special Administrative Region of China
1 shared publication - Junwei Zhou
Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China
1 shared publication - Lee Tung Chan
School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China
1 shared publication
Latest Publications
- Open Access
Characterization of the Gut Microbiome in Healthy Dogs and Dogs with Diabetes Mellitus
With a close pathogenetic resemblance to human diabetes, canine Diabetes Mellitus, a chronic metabolic disease featuring abnormally high blood sugar levels, is increasing in prevalence worldwide. Unlike humans, canine glycemic control requires life-long insulin injections and dietary control in most cases, thereby jeopardizing diabetic dogs’ quality of life and increasing the difficulty of disease control. While many research studies have focused on elucidating the relationship between the canine gut microbiome and diseases, there is currently no research on the subject of diabetes mellitus in dogs. We hypothesized that the gut microbiome of canines with diabetes mellitus is different from that of healthy controls. Thus, we performed targeted 16S rRNA sequencing and comprehensive bioinformatic analysis to compare the gut microbiome profiles of 16 diabetic dogs with those of 32 healthy dogs. Clostridioides difficile, Phocaeicola plebeius, Lacrimispora indolis, and Butyricicoccus pullicaecorum were found to be enriched in diabetic dogs. A distinct shift towards carbohydrate degradation metabolic pathways was found to be differentially abundant in the diabetic subjects. Alteration of the co-occurrence network was also evident in the diabetic group. In conclusion, our study suggests that the gut microbial landscape differs in diabetic canines at the genera, species, functional, and network levels. These findings have significant implications for disease management, and thus warrant further research.
Open AccessCharacterization of the Gut Microbiome in Healthy Dogs and Dogs with Diabetes Mellitus
With a close pathogenetic resemblance to human diabetes, canine Diabetes Mellitus, a chronic metabolic disease featuring abnormally high blood sugar levels, is increasing in prevalence worldwide. Unlike humans, canine glycemic control requires life-long insulin injections and dietary control in most cases, thereby jeopardizing diabetic dogs’ quality of life and increasing the difficulty of disease control. While many research studies have focused on elucidating the relationship between the canine gut microbiome and diseases, there is currently no research on the subject of diabetes mellitus in dogs. We hypothesized that the gut microbiome of canines with diabetes mellitus is different from that of healthy controls. Thus, we performed targeted 16S rRNA sequencing and comprehensive bioinformatic analysis to compare the gut microbiome profiles of 16 diabetic dogs with those of 32 healthy dogs. Clostridioides difficile, Phocaeicola plebeius, Lacrimispora indolis, and Butyricicoccus pullicaecorum were found to be enriched in diabetic dogs. A distinct shift towards carbohydrate degradation metabolic pathways was found to be differentially abundant in the diabetic subjects. Alteration of the co-occurrence network was also evident in the diabetic group. In conclusion, our study suggests that the gut microbial landscape differs in diabetic canines at the genera, species, functional, and network levels. These findings have significant implications for disease management, and thus warrant further research.